Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.

作者: Tsukasa Okuda , Zhongling Cai , Shouli Yang , Noel Lenny , Chuhl-joo Lyu

DOI: 10.1182/BLOOD.V91.9.3134.3134_3134_3143

关键词: BiologyHaematopoiesisLeukemiaRegulation of gene expressionProgenitor cellStem cellImmortalised cell lineImmunologyMyeloidGene targetingCancer research

摘要: The t(8;21)-encoded AML1-ETO chimeric product is believed to be causally involved in up 15% of acute myelogenous leukemias through an as yet unknown mechanism. To directly investigate the role leukemogenesis, we used gene targeting create "knock-in" allele that mimics t(8;21). Unexpectedly, embryos heterozygous for (AML1-ETO/+) died around E13.5 from a complete absence normal fetal liver-derived definitive hematopoiesis and lethal hemorrhages. This phenotype was similar seen following homozygous disruption either AML1 or CBFbeta. However, contrast AML1- CBFbeta-deficient embryos, livers AML1-ETO/+ contained dysplastic multilineage hematopoietic progenitors had abnormally high self-renewal capacity vitro. further document these growth abnormalities, retroviral transduction express murine adult bone marrow-derived progenitors. AML1-ETO-expressing cells were again found have increased could readily established into immortalized cell lines Taken together, studies suggest not only neutralizes biologic activity but also induces aberrant proliferation.

参考文章(43)
SP Romana, H Poirel, M Leconiat, MA Flexor, M Mauchauffe, P Jonveaux, EA Macintyre, R Berger, OA Bernard, High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia Blood. ,vol. 86, pp. 4263- 4269 ,(1995) , 10.1182/BLOOD.V86.11.4263.BLOODJOURNAL86114263
Shurtleff Sa, Raimondi Sc, Hancock Ml, Pui Ch, Rubnitz Je, Behm Fg, Grosveld G, Downing, Chan Gc, Buijs A, TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. ,vol. 9, pp. 1985- 1989 ,(1995)
S Meyers, S W Hiebert, N Lenny, Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene. ,vol. 11, pp. 1761- 1769 ,(1995)
Atsushi Takahashi, Masanobu Satake, Y Yamaguchi-Iwai, Suk-Chul Bae, Jie Lu, Mitsuo Maruyama, Yu Wen Zhang, Hiroya Oka, Naoko Arai, Ken-ichi Arai, None, Positive and negative regulation of granulocyte-macrophage colony- stimulating factor promoter activity by AML1-related transcription factor, PEBP2 Blood. ,vol. 86, pp. 607- 616 ,(1995) , 10.1182/BLOOD.V86.2.607.BLOODJOURNAL862607
RG Hawley, FH Lieu, AZ Fong, Teresa S Hawley, None, Versatile retroviral vectors for potential use in gene therapy. Gene Therapy. ,vol. 1, pp. 136- 138 ,(1994)
P Erickson, J Gao, KS Chang, T Look, E Whisenant, S Raimondi, R Lasher, J Trujillo, J Rowley, H Drabkin, Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood. ,vol. 80, pp. 1825- 1831 ,(1992) , 10.1182/BLOOD.V80.7.1825.BLOODJOURNAL8071825
S.E. Bodrug, B.J. Warner, M.L. Bath, G.J. Lindeman, A.W. Harris, J.M. Adams, Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. The EMBO Journal. ,vol. 13, pp. 2124- 2130 ,(1994) , 10.1002/J.1460-2075.1994.TB06488.X
Michelle M. LeBeau, Rafael Espinosa, Janet D. Rowley, Harry Drabkin, Paul Erickson, Timothy W. McKeithan, Giuseppina Nucifora, Debra J. Birn, Diane Roulston, Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis Blood. ,vol. 81, pp. 2728- 2734 ,(1993) , 10.1182/BLOOD.V81.10.2728.2728
Sheila A Shurtleff, Shari Meyers, Scott W Hiebert, Susana C Raimondi, David R Head, Cheryl L Willman, Sandra Wolman, Marilyn L Slovak, Andrew J Carroll, Frederick Behm, None, Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood. ,vol. 85, pp. 3695- 3703 ,(1995) , 10.1182/BLOOD.V85.12.3695.BLOODJOURNAL85123695